Your browser doesn't support javascript.
loading
Ionophore A23187 shows anti-tuberculosis activity and synergy with tebipenem.
Huang, Wei; Briffotaux, Julien; Wang, Xinwei; Liu, Lili; Hao, Pei; Cimino, Mena; Buchieri, Maria Virginia; Namouchi, Amine; Ainsa, Jose-Antonio; Gicquel, Brigitte.
Afiliación
  • Huang W; Emerging Bacterial Pathogens Unit, CAS Key Laboratory of Molecular Virology & Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai, China; Mycobacterial Genetics Unit, Institut Pasteur, Paris, France. Electronic address: wei.huang@pasteur.fr.
  • Briffotaux J; Emerging Bacterial Pathogens Unit, CAS Key Laboratory of Molecular Virology & Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai, China.
  • Wang X; Emerging Bacterial Pathogens Unit, CAS Key Laboratory of Molecular Virology & Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai, China.
  • Liu L; Emerging Bacterial Pathogens Unit, CAS Key Laboratory of Molecular Virology & Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai, China.
  • Hao P; Emerging Bacterial Pathogens Unit, CAS Key Laboratory of Molecular Virology & Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai, China.
  • Cimino M; Mycobacterial Genetics Unit, Institut Pasteur, Paris, France.
  • Buchieri MV; Mycobacterial Genetics Unit, Institut Pasteur, Paris, France.
  • Namouchi A; Mycobacterial Genetics Unit, Institut Pasteur, Paris, France.
  • Ainsa JA; Department of Microbiology, and BIFI, University of Zaragoza, Zaragoza, Spain; CIBERES, Instituto de Salud Carlos III, Spain.
  • Gicquel B; Emerging Bacterial Pathogens Unit, CAS Key Laboratory of Molecular Virology & Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai, China; Mycobacterial Genetics Unit, Institut Pasteur, Paris, France.
Tuberculosis (Edinb) ; 107: 111-118, 2017 12.
Article en En | MEDLINE | ID: mdl-29050757
ABSTRACT
The objective of this study was to find molecules with anti-mycobacterial activity from a natural compounds library, investigate their mechanisms of resistance, and assess their synergy with antibiotics. We screened a library of 2582 natural compounds with Mycobacterium aurum with the aim of identifying molecules with anti-mycobacterial activity. The hits with the lowest MICs in M. aurum were also tested for their antimicrobial activity in other mycobacterial species including M. tuberculosis complex strains. The chequerboard titration assay was chosen for determining drug interactions in vitro. Spontaneous resistant mutants were isolated and their whole genome sequences compared to wild type and resistant mutants to identify resistance mechanisms. We found that ionophores show anti-mycobacterial activity in vitro. Resistance mechanism to ionophores is mediated by the MmpL5-MmpS5 transporter overexpression. Ionophore A23187 enhanced beta-lactam activity in M. tuberculosis infected macrophage. It will help in the investigation of new drug combinations against bacterial infections including tuberculosis.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carbapenémicos / Calcimicina / Ionóforos de Calcio / Antibióticos Antituberculosos / Mycobacterium tuberculosis Límite: Humans Idioma: En Revista: Tuberculosis (Edinb) Año: 2017 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carbapenémicos / Calcimicina / Ionóforos de Calcio / Antibióticos Antituberculosos / Mycobacterium tuberculosis Límite: Humans Idioma: En Revista: Tuberculosis (Edinb) Año: 2017 Tipo del documento: Article